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Abstract:
The aim of present research work is to formulate and evaluate controlled release floating tablet of Ranitidine 
hydrochloride in view to enhance bioavailability and therapeutic action.The tablets were formulated by employing 
wet granulation method using PVP K 30 as binder and isopropyl alcohol as granulating fluid.  The granules were 
evaluated for flow properties. All the formulations showed values within the prescribed limits for tests like hardness, 
friability and weight variation which indicate that the prepared tablets are of standard quality. All the tablets were 
formulated using sodium bicarbonate as effervescent agent.  All the prepared formulations floated immediately after 
placing into the beaker and the floating was maintained more than 14 hrs. It was observed that the carbon dioxide 
generated from sodium  bicarbonate in presence of dissolution medium(0.1N HCL) was trapped in the polymer gel 
matrix formed by the hydration of polymer which decreases the density(<1) and makes the tablet buoyant. The 
correlation coefficient values (r) revealed that the dissolution profiles followed  Zero order kinetics and the 
mechanism of drug release was governed by Peppas model. The n values are found to be more than 0.5 (n>0.5) 
indicted that the drug release was predominantly controlled by non fickian diffusion. Based on the release rate 
constant and % of drug release  the formulations prepared with Cashew nut tree gum shown prolonged  retarding 
nature compared with the formulations prepared with Aegle marmelos gum. Among all the formulations , F3
formulation containing  drug and Cashew nut tree gum in 1:1.5 ratio  was found to be optimized formulations.
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INTRODUCTION: 
Ranitidine hydrochloride is a histamine H2-receptor 
antagonist. It is widely prescribed in active duodenal 
ulcers, gastric ulcers, Zollinger-Ellison syndrome, 
gastroesophageal reflux disease, and erosive 
esophagitis. The recommended adult oral dosage of 
ranitidine is 150 mg twice daily or 300 mg once 
daily. The effective treatment of erosive esophagitis
requires administration of 150 mg of ranitidine 4 
times a day [1]. A conventional dose of 150 mg can 
inhibit gastric acid secretion up to 5 hours but not up 
to 10 hours. An alternative dose of 300 mg leads to 
plasma fluctuations; thus a sustained release dosage 
form of Ranitidine hydrochloride is desirable [2]. The 
short biological half-life of drug (2.5±0.5 hours) also 
favors development of a sustained release 
formulation. Ranitidine hydrochloride is absorbed 
only in the initial part of the small intestine and has 
50% absolute bioavailability [3]. All these factors 
highlight the need to develop sustained release 
dosage forms of Ranitidine hydrochloride. It is also 
reported that oral treatment of gastric disorders with 
an H 2 - receptor antagonist like Ranitidine 
hydrochloride, used in combination with antacids, 
promotes local delivery of these drugs to the receptor 
of the parietal cell wall. Local delivery of these drugs 
also increases the stomach wall receptor site 
bioavailability and increases the efficacy of drugs to 
reduce acid secretion [4]. This principle may be 
applied for improving systemic as well as local 
delivery of Ranitidine hydrochloride, which would 
efficiently reduce gastric acid secretion.
The gastroretentive drug delivery system can be 
retained in the stomach and assist in improving the 
oral sustained delivery of drugs. There is a need to 
investigate a number of indigenously available 
retardant materials to make the concept of controlled 
release drug delivery more viable for the drug 
industry at more economical way. In the present 
study, natural polymers such as Aegle marmelos gum
and Cashew nut tree gum were selected for the 
preparation of floating tablets of Ranitidine 
hydrochloride. Sodium bicarbonate was used as gas 
generating agent. Tablets were prepared by wet 
granulation method using these polymers.
MATERIALS AND METHODS:  
Ranitidine hydrochloride was obtained as a gratis 
sample from Hetero labs, Hyderabad. Aegle 
marmelos gum and Cashew nut tree gum were 
purchased from Yucca enterprises, Mumbai. PVP K 
30, Isopropyl alcohol and Sodium bicarbonate were
purchased from Qualigens fine chemicals, Mumbai.
All other ingredients were of analytical grade.
Preparation of Ranitidine hydrochloride floating 
tablets
Ranitidine hydrochloride was mixed with required 
quantities of Cashew nut tree gum / Aegle marmelos 
gum, Sodium bicarbonate and Citricacid by
geometric mixing. The tablets were formulated by 
employing wet granulation method using PVP K 30 
as binder and isopropyl alcohol as granulating fluid.   
Magnesium stearate and talc were used as lubricant 
and glidant respectively. The final blend was 
compressed into tablets using 12 mm punches and 
corresponding dies on rotary tablet compression 
machine [6].The composition of each formulation 
was given in Tables 1.
Table 1: Composition of Ranitidine hydrochloride floating tablets formulated with different natural 
polymers.
Ingredients F1(mg) F2(mg) F3(mg) F4(mg) F5(mg) F6(mg)
Ranitidine hydrochloride 150 150 150 150 150 150
Cashew nut tree gum 75 150 225
Aegle marmelos gum 75 150 225
Micro crystaline 
cellulose
170 95 20 170 95 20
Sodium bicarbonate 50 50 50 50 50 50
Citricacid 25 25 25 25 25 25
Poly Vinyl Pyrolidine 20 20 20 20 20 20
Magnesium stearate 5 5 5 5 5 5
Talc 5 5 5 5 5 5
Total weight 500 500 500 500 500 500
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Evaluation Parameters
Flow properties of granules: The granules were 
evaluated for the following parameters [7].
a) Bulk density
5 gm of blend was weighed and transferred to a 
measuring cylinder. Then bulk volume was noted. 
Bulk density was calculated by using the following 
formula
Bulk density = 
Bulkvolume
owderMassofthep
b) Tapped density
5 gm of blend was weighed, transferred to a 
measuring cylinder and subjected to 100 tapings. 
Then volume was noted as tapped volume. Tapped 
density was measured by using the following formula
Tapped density = 
meTappedvolu
owderMassofthep
c)Carr’s index
Carr’s index was calculated by using the following 
formula
Carr’s index = 
ityTappeddens
yBulkdensitityTappeddens - X 100
d) Hausner’s ratio
Hausner’s ratio was calculated by using the following 
formula
Hausner’s ratio = 
yBulkdensit
ityTappeddens
e) Angle of repose
5 gm of blend was taken and poured into a hollow 
cylinder which was placed on a graph sheet. Then the 
cylinder was slowly lifted. Then height and diameter 
of the heap formed were noted down. The angle of 
repose (θ) was calculated by the formula
Angle of repose, q=Tan-1 r
h
Evaluation of Ranitidine hydrochloride floating 
tablets
a)Hardness: 
The hardness of the tablet was measured by 
Monsanto hardness tester. The lower plunger was 
placed in contact with the tablet and a zero reading 
was taken. The plunger was then forced against a 
spring by tuning a threaded bolt until the tablet 
fractured. As the spring was compressed a pointer 
rides along a gauge in the barrel to indicate the 
force[8]. The hardness was measured in terms of 
kg/cm2. 
b)Weight variation:
Formulated tablets were tested for weight uniformity, 
20 tablets were weighed collectively and 
individually. From the collective weight, average 
weight was calculated [8]. The percent weight 
variation was calculated by using the following 
formula.
c)Friability:
The Roche friability test apparatus was used to 
determine the friability of the tablets. Thirteen pre-
weighed tablets were placed in the apparatus and 
operated for 100 revolutions and then the tablets were 
reweighed. The percentage friability was calculated 
according to the following formula[8].
d) Swelling Index:
Formulated tablets were weighed individually (W0) 
and placed separately in Petri dish containing 50 ml 
of 0.1N Hydrochloric acid. The Petri dishes were 
placed in an incubator maintained at 37±0.5oC. The 
tablets were removed from the petri dish, at 
predefined intervals of time and  reweighed (Wt), and 
the % swelling index was calculated using the 
following formula[9]:
% WU = (Wt-Wo/Wo) × 100
Where:
WU – Water uptake
Wt – Weight of tablet at time t
Wo – Weight of tablet before immersion
100
Average
Variation Weight % X=
Individual Weight
Weight
100
WeightInitial
WeightFinal-Weight Initial
Friability X=
- AverageWeight 
IAJPS 2017, 4 (02), 327-335 Md Musharraf Ali and  V.Saikishore ISSN 2349-7750
w w w . i a j p s . c o m Page 330
Table 2: Micromeritic properties of granules of Ranitidine hydrochloride floating tablets formulated with 
different concentrations of natural polymers.
Formulation 
code
Angle of 
repose (°)
Bulk density 
(gm/cm3)
Tapped density 
(gm/cm3)
Carr’s index (%) Hausner’s ratio
F1 26.72 0.520 0.616 15.58 1.184
F2 25.90 0.523 0.617 15.23 1.180
F3 25.41 0.527 0.619 14.86 1.175
F4 27.32 0.516 0.611 15.54 1.184
F5 26.94 0.519 0.613 15.49 1.183
F6 26.31 0.521 0.615 15.28 1.180
Table 3: Physical properties of Ranitidine hydrochloride floating tablets formulated with different 
concentrations of natural polymers.
e) In vitro buoyancy study:
This test is characterized by floating lag time and 
total floating time. The test was performed using 
USP-Type II paddle apparatus using 900 ml of 0.1N 
Hydrochloric acid at paddle rotation of 100 rpm at 37 
± 0.50 C. The time required for tablet to rise to 
surface of dissolution medium and duration of time 
the tablet constantly float on dissolution medium was 
noted as floating lag time and total floating time [10].
f) Drug content:
20 tablets were weighed and powdered the powder 
weight equivalent to 150mg of  Ranitidine 
hydrochloride was  dissolved in 100ml of 0.1N 
Hydrochloric acid and filtered. 5ml of this was 
diluted to 50ml with water and drug content was 
estimated at 315 nm by UV spectrophotometer [11]
Formulation
Hardness
(kg/cm2)
Weight 
variation (mg)
Friability
(%)
Drug content 
(%)
Floating
Lag time
Total  
floating 
time (hrs)
F1 4.5±0.021 501.32±0.24 0.40±0.010 100.14±0.13 2.25 min >14
F2 4.7±0.025 500.65±0.28 0.34±0.018 99.78±0.15 2.12 min >14
F3 4.8±0.032 499.83±0.39 0.25±0.024 99.56±0.11 1.23 min >14
F4 4.3±0.011 500.23±0.13 0.45±0.015 99.54±0.12 2.36 min >14
F5 4.5±0.022 501.12±0.18 0.36±0.021 99.68±0.11 2.17 min >14
F6 4.7±0.016 499.66±0.23 0.28±0.013 99.73±0.17 1.52 min >14
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Table 4: In vitro drug release kinetic data of Ranitidine hydrochloride floating tablets formulated with 
different concentrations of natural polymers
Formulation
Correlation Coefficient Value Release Rate 
Constant
(mg/hr)k0
Exponential 
Coefficient
(n)
T50
(hr)
T90
(hr)Zero 
Order
First 
Order
Matrix Peppas
F1
0.9916 0.8293 0.9524 0.9963 15.33 0.7551 4.9 8.8
F2 0.9951 0.8058 0.9440 0.9964 13.70 0.7976 5.5 9.9
F3 0.9996 0.7313 0.9269 0.9998 12.70 0.9730 5.9 10.6
F4 0.9917 0.8358 0.9256 0.9966 16.12 0.7592 4.6 8.4
F5 0.9950 0.7892 0.9454 0.9968 14.4 0.8018 5.2 9.3
F6 0.9996 0.7801 0.9264 0.9998 13.06 0.9697 5.7 10.3
Table 5: Swelling index values of Ranitidine hydrochloride floating tablets formulated with different 
concentrations of natural polymers
Fig 1: Comparative in vitro drug release profile of Ranitidine hydrochloride floating tablets formulated with 
different concentrations of Cashew nut tree gum
(-♦-)Floating tablets formulated with  drug and Cashew nut tree gum in  1:0.5 ratio
(-■-)Floating tablets formulated with  drug and Cashew nut tree gum in  1:1 ratio
(-×-)  Floating tablets formulated with  drug and Cashew nut tree gum in  1:1.5 ratio
Formulation code
Swelling index
Time in hours
after 1 hour after 2 hours after 8hours
F1 54.34 78.93 149.24
F2 57.45 91.46 157.23
F3 60.12 98.56 171.39
F4 52.69 76.64 145.00
F5 55.24 89.89 154.00
F6 58.53 96.10 168.50
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Fig 2: Comparative in vitro drug release profile of Ranitidine hydrochloride floating tablets 
formulated with different concentrations of Aegle marmelos gum
(-♦-)Floating tablets formulated with  drug and Aegle marmelos gum in  1:0.5 ratio
(-■-)Floating tablets formulated with  drug and Aegle marmelos gum in  1:1 ratio
(-×-)   Floating tablets formulated with  drug and Aegle marmelos gum in  1:1.5 ratio
Fig 3 - FTIR spectrum of Ranitidine hydrochloride
Fig 4- FTIR spectrum of Ranitidine hydrochloride  floating  tablet  prepared with Cashew nut tree gum
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Fig 5 - FTIR spectrum of Ranitidine hydrochloride floating tablet prepared with Aegle marmelos gum
g) In vitro dissolution test:
The release of Ranitidine hydrochloride from the 
tablet was studied using USP-Type II paddle 
apparatus. Drug release profile was carried out in 900 
ml of 0.1N Hydrochloric acid maintained at 37 ± 
0.5°C temperatures at 100 rpm. 5 ml of samples were 
withdrawn at regular time intervals. The samples was 
replaced by its equivalent volume of dissolution 
medium and was filtered through 0.45 µm Whatman 
filter paper and analyzed at 315 nm by UV 
spectrophotometer [12].
Drug Excipient Compatibility Studies:
Fourier Transform Infrared (FTIR) Spectroscopy 
studies were used for the evaluation of 
physicochemical compatibility and interactions, 
which helps in the prediction of interaction of the 
drug with Cashew nut tree gum / Aegle marmelos 
gum used in tablet formulations[13]. 
Stability studies of  optimized floating matrix 
tablets:
The optimized  floating matrix tablets were separated 
in to two groups.  Each group of formulations were 
placed separately in stability chamber which is 
maintained at 25±5oC/60% RH and 40±5oC/75% RH 
respectively for three months and every month the 
formulations from each group were subjected to 
dissolution studies and % drug release was calculated
[14].
RESULTS AND DISCUSSION:
Floating tablets  of Ranitidine hydrochloride were 
prepared by varying the concentration of  Cashew nut 
tree gum (F1-F3)  and Aegle marmelos gum (F4-F6) . 
The formulated granules were evaluated for various 
flow properties. The bulk density for all the 
formulations ranged from 0.516 to 0.527. The angle 
of repose for all the formulations was found to be in 
the range of  25041l-270 621. The Carr’s index for all 
the formulations ranged from 15.58 – 14.86%. The 
value of bulk density indicates good packing 
characters. The value of angle of repose (250-300) for 
all the formulations indicates good flow property. 
The value of Carr’s index (10-16%) indicates free 
flowing material. The values of Hausner’s ratio were 
found to be between 1.175-1.184. The powder blend 
with Hauser’s ratio of 1.25 has good flow properties. 
So the values indicate that the granules had 
acceptable flow properties. The flow properties were 
shown in table 2.
Floating matrix tablets were evaluated for hardness 
and friability. The hardness was found to be in 
between 4.5 – 4.8 kg. The tablets satisfied friability 
requirement, as the % friability values were less than 
1%.The drug content estimations showed values in 
the range of 99.54 to 100.14%, which reflects good 
uniformity in drug content among different 
formulations. All the tablets passed weight variation 
test as the % weight variation was within the 
Pharmacopoeia limits of ±5% of the weight. All the 
formulations showed values within the prescribed 
limits for tests like hardness, friability and weight 
variation which indicate that the prepared tablets are 
of standard quality. 
All the tablets were formulated using sodium 
bicarbonate as effervescent agent.  All the prepared 
formulations floated immediately after placing into 
the beaker and the floating was maintained more than 
14 hrs. It was observed that the carbon dioxide 
generated from sodium  bicarbonate in presence of 
dissolution medium(0.1N HCL) was trapped in the 
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polymer gel matrix formed by the hydration of 
polymer which decreases the density(<1) and makes 
the tablet buoyant. The results of various physical 
properties and invitro buoyancy studies were 
tabulated in table 3.
In vitro dissolution studies of all the formulations of 
floating matrix tablets were carried out in 0.1N HCl. 
The study was performed for 12 hrs and the 
cumulative drug release was calculated. All the 
formulations remained floating and intact throughout 
the dissolution studies. The formulations(F1-F3) 
containing  Gum kondagogu showed decrease in drug 
release with increase in concentration of Gum 
kondagogu . The drug release from formulation F3 
containing  drug and natural polymer in 1:1.5 ratio  
showed a maximum drug release at end of 12 hours.
The dissolution profile for the formulations F1- F3 
was shown in figure 1. The formulations(F4-F6) 
containing  Aegle marmelos gum showed decrease in 
drug release with increase in concentration of Aegle 
marmelos gum. The drug release from formulation F3 
containing  drug and natural polymer in 1:1.5 ratio  
showed a maximum drug release at end of 11.5 
hours. The dissolution profile for the formulations 
F4- F6 was tabulated in table 6.11 and shown in 
figure 2.
To ascertain the mechanism of drug release, the 
dissolution data was analyzed by zero order, first 
order, and Higuchi and Peppas equations. The 
correlation coefficient values (r) revealed that the 
dissolution profiles followed  Zero order kinetics and 
the mechanism of drug release was governed by 
Peppas model. The n values are found to be more 
than 0.5 (n>0.5) indicted that the drug release was 
predominantly controlled by non fickian diffusion. 
The in-vitro drug release kinetic data was shown in 
Table 4.The swelling index studies showed a gradual 
increase with increase in concentration of natural 
polymer and were shown in  Table 5.
The characteristics peaks confirmed the structure of 
Ranitidine hydrochloride . The same peaks were also 
reported in all drug loaded matrix tablet. There were 
no change or shifting of the characteristic peaks in 
matrix tablets suggested that there was no significant 
drug polymer interaction which indicates the stable 
nature of the drug in all formulations. Drug release 
from optimized formulations  before and after storage 
under varying conditions were  evaluated periodically 
at the regular interval of every month.  The drug 
release profiles of all the formulations did not change 
significantly after storage at 25±2° C/60±5% RH and 
40±2° C/75±5% RH for a period of 3 months. There 
is no significant difference in the drug content and  
release rate constants.The results indicated that the 
drug release from the optimized formulations  were 
found  to be quite stable.
CONCLUSION:
From the above results ,it is clearly evident that the 
invitro release of  Ranitidine hydrochloride from the 
floating tablet was influenced by nature of natural 
polymer. Based on the release rate constant and % of 
drug release the formulations prepared with Cashew 
nut tree gum shown prolonged retarding nature 
compared with the formulations prepared with Aegle 
marmelos gum. Among all the formulations , F3
formulation containing  drug and Cashew nut tree 
gum in 1:1.5 ratio was found to be optimized 
formulations.
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